The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

(Reuters) -Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top ...